
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Tropicamide
Therapeutic Area : Ophthalmology
Study Phase : Undisclosed
Sponsor : Sundets Ögonläkare
Deal Size : Inapplicable
Deal Type : Inapplicable
Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera
Details : Mydriacyl (Tropicamide) is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Glaucoma.
Product Name : Mydriacyl
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 04, 2022
Lead Product(s) : Tropicamide
Therapeutic Area : Ophthalmology
Highest Development Status : Undisclosed
Sponsor : Sundets Ögonläkare
Deal Size : Inapplicable
Deal Type : Inapplicable
